NQO1 and breast neoplasm: Indeed, we observed differences in the relative ability of BSO or β-lapachone to sensitize individual PDXs to phenformin treatment (Fig. 8g, h), suggesting that breast tumors likely differ in their reliance on glutathione and/or NQO1 to maintain redox balance.